AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $30.96
- 52-wk low
- $19.69
- Prev close
- $24.86
- Mkt cap
- $5.17B
- P/E
- 13.6x
- Fwd P/E
- 73.5x
Smart money
Earnings
Earnings came in $0.12 a share above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $278.6M | $284.0M | $268.1M | $308.0M |
| Cost of what it sold | $21.6M | $26.2M | $24.8M | $28.3M |
| Gross profit | $257.0M | $257.8M | $243.3M | $279.6M |
| What it spent | ||||
| Research and development | $87.8M | $84.8M | $76.9M | $81.6M |
| Sales and admin | $133.4M | $155.6M | $171.0M | $160.3M |
| Total operating expenses | $221.2M | $240.4M | $247.9M | $241.8M |
| What was left | ||||
| Operating profit | $35.8M | $17.4M | -$4.6M | $37.8M |
| Profit before tax | $44.6M | $26.3M | $4.0M | $46.5M |
| Tax | -$27.2M | -$247.2M | $344.0K | $15.0M |
| Net profit | $71.8M | $273.6M | $3.6M | $31.5M |
| EBITDA | $47.5M | $29.2M | $7.0M | $32.4M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
29 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Virtus Advisers LLC Makes New Investment in ACADIA Pharmaceuticals Inc. $ACAD
Leans bullishAug 21Great Lakes Advisors LLC Purchases New Holdings in ACADIA Pharmaceuticals Inc. $ACAD
Leans bullishAug 21ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 1-Year High - Here's What Happened
BullishAug 18
